Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00773175 · ClinicalTrials.gov registry record · Phase 4
Subcutaneous Rehydration Compared to Intravenous Rehydration
A Phase 4 study, sponsored by Halozyme Therapeutics.
- Completed
- Registry status
- Phase 4
- Development phase
- 148
- Enrollment target
NCT00773175 is a Phase 4 study that has completed, run by Halozyme Therapeutics. The registered enrollment target is 148 participants.
The verdict
NCT00773175, a Phase 4 study, has completed, sponsored by Halozyme Therapeutics.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 148 participants
- Enrollment target
Study Summary
Randomized (1:1 ratio) study of subcutaneous (SC) versus intravenous (IV) fluid rehydration in mildly to moderately dehydrated pediatric patients.
Interventions
- DRUG recombinant human hyaluronidase
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2008-10 |
| Est. Completion | 2009-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00773175
The ClinicalTrials.gov registry entry for NCT00773175 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Halozyme Therapeutics, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which recombinant human hyaluronidase is the first listed.
NCT00773175 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00773175 about?
NCT00773175 is a clinical study titled "Subcutaneous Rehydration Compared to Intravenous Rehydration". Randomized (1:1 ratio) study of subcutaneous (SC) versus intravenous (IV) fluid rehydration in mildly to moderately dehydrated pediatric patients.
What is the current status of trial NCT00773175?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 148 participants. The study started on 2008-10. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00773175?
The interventions under investigation include: recombinant human hyaluronidase (DRUG).
Who is sponsoring clinical trial NCT00773175?
This trial is sponsored by Halozyme Therapeutics, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.